Kenya has signed a Global Fund Grant of USD 407,989,068 (Ksh 59.7Billion) to support HIV, Tuberculosis (TB) and Malaria interventions.
In a statement on June 24, the ministry of health announced that the funds will strengthen health and community systems during the implementation period of three years.
“Kenya has today signed six Global Fund grants amounting to Ksh 59.7 billion to support HIV, TB & Malaria intervention and strengthen health and community systems during the implementation period between July 2024 to June 2027,” the statement reads in part.
The ministry further noted that out of the total funds, Ksh 30billion will go to HIV, Ksh 9.4billion for Malaria, Ksh 8.7 billion for Tuberculosis (TB) and Ksh 4.4 allocated for Health systems strengthening.
The Global Fund has supported Kenya since 2003, significantly contributing to the country’s tremendous achievements.
The fund has supported the procurement of essential commodities such as antiretrovirals (ARVs), HIV test kits, condoms, and laboratory reagents.
Additionally, it has funded programmatic interventions in health facilities at the community level.
Also Read: Govt Flags Ministry of Health Mass Recruitment Advert
The Global Fund is a partnership between Governments, civil society, the private sector and people affected by diseases designed to accelerate the end of AIDS, Tuberculosis and Malaria epidemics globally.
Kenya HIV and TB Success Rate
Following the partnership, there has been a remarkable decline in new HIV infections, HIV-related mortality, and mother-to- child transmission by 78%, 68%, and 65% respectively.
These significant reductions result from increased access to HIV testing, treatment, and prevention services at both community and facility levels.
Currently, nearly 1.4 million people living with HIV are receiving lifesaving treatment at various facilities nationwide.
Furthermore, this progress is credited to the decentralization of HIV services and the collaboration between the government, development partners, non-state actors, stakeholders, counties, and communities.
Also Read: KEMSA Boss Addresses Reports on Kenyans Receiving False HIV Test Results
Courtesy of the TB programme, the ministry of health has recorded a treatment success rate of 86% with the average positivity rate among TB presumptive cases declined from 7.35% in 2021 to 5.6% in March 2024 while the absolute number tested more than doubled from 245,902 in 2021 to 502,970 in March 2024.
Likewise, the Fund has partnered with the Government of Kenya and provided support for the establishment of 1,933 community health units.
It has also trained 18,500 community health promoters (CHPS) and 3,700 Community Health Extension Workers (CHEWs).
Similarly, the Fund has supported the establishment of 1,933 community health units in partnership with the Government of Kenya.
In addition, the programme has contributed to the overall reduction of malaria burden in Kenya, with the national level prevalence declining from 8.2% in 2015 to 6% in 2023.
Kenya Partnership with Global Fund
Through a partnership with the Government of Kenya, the Global Fund has invested US$ 9.5 m in the construction, equipping and digitization of KEMSA National Supply Chain Centre.
This investment will boost the supply chain, improve service delivery at primary health care levels, and, with sufficient storage, enhance responses to pandemics and emergencies caused by climate change.
In addition, it is a good example of multi-partner investment over a period of time as building resilient systems takes a lot of time and resilience.
The ministry of health congratulated the Kenya MSA citing that the partnership will support in the provision of quality care and prevention services for all people with TB, leprosy and lung diseases.
Areas The New Global Grant will Support
The new Global grant is set to support in the provision of quality care and prevention services for all people with TB, leprosy and lung diseases.
Further, it will contribute to the attainment of Universal Health Coverage through comprehensive prevention, treatment, and care for HIV, while also aiming to reduce malaria incidence and deaths by at least 75 percent by 2027.
It also seeks to strengthen health systems at the facility and community levels, including procurement of TB, malaria, and HIV commodities such as medicines, laboratory supplies, and test kits.
The grant will support primary health care activities at the community level in alignment with the universal health care agenda.
This includes providing social support and covering Social Health Insurance Fund (SHIF) premiums for TB/HIV/Malaria patients in need, ensuring access to the full SHIF benefit
Follow our WhatsApp Channel for real-time news updates!
https://whatsapp.com/channel/0029VaB3k54HltYFiQ1f2i2C
